Characteristics of Patients With Hematologic Malignancies Who Received Palliative Care Consultation Services in a Medical Center

American Journal of Hospice and Palliative Medicine

Volumn 30, Issue 8, 2013, Pages 773-780

  Hung, Yu Shin ^a   Wu, Jin Hou ^a   Chang, Hung ^a   Wang, Po Nan ^a   Kao, Chen Yi ^a   Wang, Hung Ming ^a   Liau, Chi Ting ^a   Chen, Jen Shi ^a   Lin, Yung Chang ^a   Su, Po Jung ^a   Hsieh, Chia Hsun ^a   Chou, Wen Chi ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

bleeding; hematologic malignancy; infection; palliative care; solid cancer; symptoms

Indexed keywords

HEMATOLOGIC DISEASE; HUMAN; NEOPLASMS; PALLIATIVE THERAPY; PATIENT REFERRAL; RETROSPECTIVE STUDY;

HEMATOLOGIC NEOPLASMS; HUMANS; NEOPLASMS; PALLIATIVE CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 84888209276     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909112471423     Document Type: Article

References (27)

1. Smith A,Roman E,Howell D,Jones R,Patmore R,Jack A.The haematological malignancy research network (HMRN): a new information strategy for population based epidemiology and health service research.Br J Haematol. 2010;148 (5): 739-753.
2. Swerdlow SHCE,LHarris N,Jaffe E, et alWHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.Lyon, France: International Agency for Research on Cancer; 2008:.
3. Maddocks I,Bentley L,Sheedy J.Quality of life issues in patients dying from haematological diseases.Ann Acad Med Singapore. 23 (2): 244-248.
4. Cheng WW,Willey J,Palmer JL,Zhang T,Bruera E.Interval between palliative care referral and death among patients treated at a comprehensive cancer center.J Palliat Med. 8 (5): 1025-1032.
5. Elsayem A,Fadul N,Zhang K,Palmer JL,Bruera E.Predictors of access to palliative care in patients who died in a comprehensive cancer center.J Palliat Med. 2007;10 (5): 1146-1152.
6. Earle CC,Neville BA,Landrum MB,Ayanian JZ,Block SD,Weeks JC.Trends in the aggressiveness of cancer care near the end of life.J Clin Oncol. 2004;22 (2): 315-321.
7. Howell DA,Shellens R,Roman E,Garry AC,Patmore R,Howard MR.Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data.Palliat Med. 2011;25 (6): 630 641.
8. Fadul NA,El Osta B,Dalal S,Poulter VA,Bruera E.Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors.J Palliat Med. 11 (3): 422-427.
9. Improving Outcomes in Haematological Cancers: The Manual. London, England: National Institute for Clinical Excellence; 2003:.
10. Smith TJ,Temin S,Alesi ER, et al.American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care.J Clin Oncol. 2012;30 (8): 880-887.
11. Republic of China: Bureau of Health Promotion, Department of Health, Executive Yuan, Republic of China; 2011:.
12. Hung YS,Chen CH,Yeh KY, et al.Potential benefits of palliative care for polysymptomatic late-stage nonmalignant patients in Taiwan.J Formos Med Assoc. In press;:.
13. Symptoms Record Form in patients with terminal illness disease for hospice consultation care nurse specialist. Taiwan, Republic of China: bureau of national health insurance. http://www.nhi.gov.tw/information/bbs_detail.aspx?bulletin_ID1/41404&menu1/49&menu_id1/4545. Accessed September 10, 2012.
14. Hung YS,Chang H,Wu WS,Chen HS,Chou WC.A comparison of cancer and non-cancer patients who receive palliative care consultation services [published online ahead of print October 3, 2012].Am J Hosp Palliat Care. 2012;:.
15. Chang VT,Hwang SS,Feuerman M,Kasimis BS,Thaler HT.The memorial symptom assessment scale short form (MSAS-SF).Cancer. 2000;89 (5): 1162-1171.
16. Hwang SS,Chang VT,Cogswell J, et al.Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model.J Pain Symptom Manage. 2004;28 (5): 421-432.
17. Walsh D,Donnelly S,Rybicki L.The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients.Support Care Cancer. 2000;8 (3): 175-179.
18. Stalfelt AM,Brodin H,Pettersson S,Eklof A.The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain.Leuk Res. 2003;27 (6): 481-488.
19. Cleeland CS,Mendoza TR,Wang XS, et al.Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.Cancer. 2000;89 (7): 1634-1646.
20. Bauduer F,Capdupuy C,Renoux M.Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases.Support Care Cancer. 2000;8 (4): 302-306.
21. Oneschuk D,Fainsinger R,Demoissac D.Antibiotic use in the last week of life in three different palliative care settings.J Palliat Care. 2002;18 (1): 25-28.
22. Abduh Al-Shaqi M,Alami AH,Zahrani AS,Al-Marshad B,Muammar AB,M Z AS.The pattern of antimicrobial use for palliative care in-patients during the last week of life.Am J Hosp Palliat Care. 2012;29 (1): 60-63.
23. Boyce A,McHugh M,Lyon P.Proactive palliative care choices for haematology day patients.Int J Palliat Nurs. 2003;9 (12): 544-550.
24. Glass E.Different approaches to transfusion practices used in hospice care.Oncol Nurs Forum. 1996;23 (1): 117-118.
25. Loke SS,Rau KM,Huang CF.Impact of combined hospice care on terminal cancer patients.J Palliat Med. 2011;14 (6): 683-687.
26. Temel JS,Greer JA,Muzikansky A, et al.Early palliative care for patients with metastatic nonsmall-cell lung cancer.N Engl J Med. 2010;363 (8): 733-742.
27. Auret K,Bulsara C,Joske D.Australasian haematologist referral patterns to palliative care: lack of consensus on when and why.Intern Med J. 2003;33 (12): 566-571.